State ex rel. Borling v. State Teachers Retirement Sys. Bd.

2023 Ohio 838
CourtOhio Court of Appeals
DecidedMarch 16, 2023
Docket22AP-294
StatusPublished

This text of 2023 Ohio 838 (State ex rel. Borling v. State Teachers Retirement Sys. Bd.) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State ex rel. Borling v. State Teachers Retirement Sys. Bd., 2023 Ohio 838 (Ohio Ct. App. 2023).

Opinion

[Cite as State ex rel. Borling v. State Teachers Retirement Sys. Bd. of Ohio, 2023-Ohio-838.]

IN THE COURT OF APPEALS OF OHIO

TENTH APPELLATE DISTRICT

State of Ohio, ex rel. : Darlene Borling, : No. 22AP-294 Relator-Appellee, (C.P.C. No. 20CV-7365) : (REGULAR CALENDAR) v. :

State Teachers Retirement : System Board of Ohio, : Respondent-Appellant. :

D E C I S I O N

Rendered on March 16, 2023

On brief: Seeley, Savidge, Ebert & Gourash, Co., LPA, Gary A. Ebert, and Clare C. Moran for appellee. Argued: Clare C. Moran.

On brief: Dave Yost, Attorney General, Samuel A. Peppers, III, and Lisa A. Reid for appellant. Argued: Lisa A. Reid.

APPEAL from the Franklin County Court of Common Pleas

MENTEL, J. {¶ 1} Respondent-appellant, State Teachers Retirement System Board of Ohio (“STRS”), appeals from a May 12, 2022 decision and entry of the Franklin County Court of Common Pleas granting the request for a writ of mandamus of relator-appellee, Darlene Borling (“Borling”), to remand this action to STRS for review of her disability application to consider whether her mixed connective tissue disorder (“MCTD”), is a disabling condition entitling her to disability benefits. For the reasons that follow, we affirm. No. 22AP-294 2

I. FACTS AND PROCEDURAL HISTORY {¶ 2} Borling was employed as a teacher with Columbia Local School District and is a member of STRS. Borling last worked as a teacher on February 22, 2019. On March 8, 2019, Borling was admitted at the Cleveland Clinic for treatment related to cryptococcal meningitis (“CM”). (Jan. 6, 2021 Record of Proceedings at 0F364-N91.) Borling was discharged on March 21, 2019.1 On March 26, 2019, Borling was readmitted to the hospital experiencing “[f]evers * * * likely attributable to an IRIS syndrome or her connective tissue disease.” (Record of Proceedings at 0F364-N77.) Borling was later discharged on April 3, 2019. Borling’s internist, Dr. Rena Bose (“Bose”), provided treatment for CM and recommended follow up with a rheumatologist for “underlying [m]ixed connective tissue disorder.” (Record of Proceedings at 0F364-N80.) {¶ 3} On April 26, 2019, Borling filed an application for disability benefits with STRS. The application included an attending physician’s report by Bose and medical records from the Cleveland Clinic. According to the application, Borling identified Bose as the physician treating her primary disabling medical condition, CM, and noted her admission to the Cleveland Clinic on both March 8 and March 26, 2019. (Record of Proceedings at 0F364-N66.) In section 7, Borling consented to the release of medical reports from both Bose and her rheumatologist, Dr. Judith Manzon (“Manzon”). (Record of Proceedings at 0F364-N67.) {¶ 4} Borling provided an Attending Physician’s Report by Bose with her application.2 In the report, Bose identified CM as Borling’s primary disabling condition and listed MCTD and amyloidosis as “[o]ther significant medical condition(s).” (Record of Proceedings at 0F364-N74.) Bose indicated that both CM and MCTD were disabling conditions.3 In the recommendation section, Bose certified Borling was disabled by CM and expected to last 12 or more months. Bose provided various medical records from Borling’s March 8 and March 26, 2019 hospitalizations at the Cleveland Clinic. Of note, the

1 Of note, the hospital’s discharge summary documented Borling’s past medical history for “RRMS on no DMT,

MCTD, localized amyloidosis, and mesenteric panniculitis on chronic steroids.” (Emphasis added.) (Record of Proceedings at 0F364-N91.) 2 Per the instructions provided in the applications, “[c]onditions listed as disabling will only be reviewed if

standard objective medical evidence is provided.” (Record of Proceedings at 0F364-N74.) 3 The form states that the Attending Physician’s Report should be provided by the physician treating the

applicant’s “primary disabling medical condition” and “[o]nly one Attending Physician’s Report is required.” (Emphasis sic.) (Record of Proceedings at 0F364-N66.) No. 22AP-294 3

medical records confirmed Borling was being treated for both CM and MCTD during this period. (See Record of Proceedings at 0F364-N76-77, N80.) {¶ 5} In a letter dated April 26, 2019, STRS informed Borling that “more disability application information [was] required” asking Borling to “have [her] physician submit the discharge summary from [her] stay at Cleveland Clinic Main Campus.” (Record of Proceedings at 0F364-P59.) STRS did not seek any other information or note any deficiencies in the application at that time. STRS received the requested discharge summaries on May 2, 2019. Relevant to the instant appeal, additional evidence of Borling’s connective tissue disease was included in the records. STRS deemed Borling’s application complete on May 2, 2019. (Record of Proceedings at 0F364-O82.) {¶ 6} On May 7, 2019, Dr. Martin Gottesman (“Gottesman”), on behalf of the STRS Medical Review Board, advised Borling a period of treatment of six-months was needed prior to any determination of disability. Gottesman reasoned that “[t]his is based on the current information in the medical records which indicate disability for medical reasons.” (Record of Proceedings at 0F364-O7.) On May 8, 2019, STRS notified Borling that her completed application was received and wrote “[e]xaminations for determining eligibility for disability benefits will be assigned by the Medical Review Board only for conditions listed as permanently disabling and supported with medical evidence by your physician(s). Your attending physician(s) provided support for the following condition, [CM], to be processed.” (Record of Proceedings at 0F364-P60.) {¶ 7} Borling sought additional treatment during the six-month period. The records provided include progress notes from Borling’s June 13, 2019 examination with Manzon noting Borling’s diagnosis of “[u]ndifferentiated connective tissue disease.” (Record of Proceedings at 0F364-O16.) On July 22, 2019, Borling provided additional medical records to STRS that included a July 17, 2019 letter from her infectious disease physician, Dr. Patricia Bartley (“Bartley”). Bartley “certif[ied]” that Borling has been under her care for CM “complicated with immune reconstitution syndrome in setting immunosuppression from multiple sclerosis, undifferentiated connective tissue disease, [and] amyloidosis (likely AA), localized around mid trachea, Hx of chronic pulmonary nodules mesenteric panniculitis, requiring Medrol dose between 2 to 6 mg.” (Record of Proceedings at 0F364-O26.) Bartley recommended that Borling not return to work and No. 22AP-294 4

should continue with restrictions. On October 31, 2019, Borling provided additional medical records regarding her treatment for both CM and MCTD. These records included an October 17, 2019 letter from Bartley recounting Borling’s treatment and diagnosis for, among other things, undifferentiated connective tissue disease. (Record of Proceedings at 0F364-O52.) The records also included a letter from Bose that stated Borling was still receiving treatment for CM and still suffered from, among other diagnoses, connective tissue disease. (Record of Proceedings at 0F364-O64.) {¶ 8} On November 7, 2019, STRS instructed Dr. Donald Mann (“Mann”), to provide an independent medical examination of Borling “only on the condition of [CM].” (Record of Proceedings at 0F364-P69.) On December 12, 2019,4 Mann provided a report of his examination. Mann began his report qualifying his findings noting that his review was limited to examining whether CM was a disabling condition. (Record of Proceedings at 0F364-O78.) Mann found,”[Borling] experienced a bout of [CM] earlier this year which required intense treatment. From that condition she has recovered.” (Record of Proceedings at 0F364-O80.)5 Mann concluded that Borling was not disabled for CM as she

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State Ex Rel. Bruce v. State Teachers Retirement Board
795 N.E.2d 110 (Ohio Court of Appeals, 2003)
State ex rel. Ewart v. State Teachers Retirement Sys. Bd.
2019 Ohio 2459 (Ohio Court of Appeals, 2019)
State v. Wade
2019 Ohio 2469 (Ohio Court of Appeals, 2019)
State ex rel. Ewart v. State Teachers Ret. Sys. Bd. of Ohio
2020 Ohio 4147 (Ohio Court of Appeals, 2020)
State ex rel. Hayslip v. State Teachers Ret. Sys. Bd.
2021 Ohio 3495 (Ohio Court of Appeals, 2021)
Blakemore v. Blakemore
450 N.E.2d 1140 (Ohio Supreme Court, 1983)
State ex rel. Hulls v. State Teachers Retirement Board
866 N.E.2d 483 (Ohio Supreme Court, 2007)
State ex rel. Marchiano v. School Employees Retirement System
902 N.E.2d 953 (Ohio Supreme Court, 2009)
State ex rel. Menz v. State Teachers Retirement Board
40 N.E.3d 1083 (Ohio Supreme Court, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
2023 Ohio 838, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-ex-rel-borling-v-state-teachers-retirement-sys-bd-ohioctapp-2023.